Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/376270 stock hub

KOSDAQ/376270 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/376270is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
498.7B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/376270
In the news

Latest news · KOSDAQ/376270

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-151.4
P25 n/aP50 n/aP75 n/a
ROIC-33.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/376270 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
155
Groups with data
11
Currency
KRW
Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

14
MetricValue
Country
South Korea
Country code
KR
Enterprise value
KRW 504.4B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
KRW 498.7B
Price
KRW 69,500
Price currency
KRW
Sic
2834
Symbol
kosdaq/376270
Website
https://www.hempharma.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-4.78%
EV Earnings
-21.16x
EV/FCF
-27.87x
EV/Sales
38.87x
FCF yield
-3.63%
P/B ratio
95.64x
P/S ratio
38.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

12
MetricValue
EBIT Margin
-120.06%
EBITDA Margin
-100.07%
Gross margin
4.81%
Gross Profit
KRW 624M
Gross Profit Growth
-61.38%
Net Income
KRW -23.8B
Pretax Margin
-182.75%
Profit Margin
-183.69%
ROA
-21.96
ROCE
-137.3
ROE
-151.4
ROIC
-33.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

3
MetricValue
Cagr1y
228.87%
Revenue Growth
-13.86x
Revenue Growth Q
-41.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
KRW 0.29
Assets
KRW 51.8B
Cash
KRW 13.8B
Current Assets
KRW 22.6B
Current Liabilities
KRW 40.5B
Debt
KRW 19.3B
Debt Equity
KRW 3.69
Debt FCF
KRW -1.06
Equity
KRW 5.2B
Interest Coverage
-24.01
Liabilities
KRW 46.6B
Long Term Assets
KRW 29.2B
Long Term Liabilities
KRW 6.1B
Net Cash
KRW -5.5B
Net Cash By Market Cap
KRW -1.1
Net Debt Equity
KRW 1.05
Tangible Book Value
KRW 3.5B
Tangible Book Value Per Share
KRW 497

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.56
Inventory Turnover
9.96
Net Working Capital
KRW -17.6B
Quick ratio
0.38
Working Capital
KRW -17.9B
Working Capital Turnover
KRW -2.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-10.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
228.61%
200-day SMA
45,954.9
50-day SMA
67,494
50-day SMA vs 200-day SMA
50over200
All Time High
97,500
All Time High Change
-28.72%
All Time High Date
2026-01-29
All Time Low
11,520
All Time Low Change
503.3%
All Time Low Date
2024-11-25
ATR
4,652.5
Beta1y
0.16
Beta2y
-0.04
Ch YTD
51.58
High
71,000
High52
97,500
High52 Date
2026-01-29
High52ch
-28.72%
Low
61,100
Low52
18,000
Low52 Date
2025-08-06
Low52ch
286.11%
Ma50ch
2.97%
Price vs 200-day SMA
51.24%
RSI
59.85
RSI Monthly
75.97
RSI Weekly
57.91
Sharpe ratio
2.02x
Sortino ratio
3.98
Total Return
-10.69%
Tr YTD
51.58
Tr1m
9.45%
Tr1w
13.01%
Tr3m
-21.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
KRW -15.6B
Operating margin
-120.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
4,235,901%
Net Borrowing
19,726,561,580
Shares Insiders
26.52%
Shares Institutions
4.35%
Shares Out
7,176,187
Shares Qo Q
1.26%
Shares Yo Y
10.69%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
KRW -19B
Average Volume
24,332.6x
Bv Per Share
702.2
CAPEX
KRW -9.8B
Ch1m
9.45
Ch1w
13.01
Ch1y
228.6
Ch3m
-21.38
Ch6m
162.3
Change
13.01%
Change From Open
13.75
Close
61,500
Days Gap
-0.65
Depreciation Amortization
2,594,935,000
Dollar Volume
6,268,830,500
Earnings Date
2026-05-28
EBIT
KRW -15.6B
EBITDA
KRW -13B
EPS
KRW -3,389
F Score
1
FCF
KRW -18.1B
FCF EV Yield
-3.59x
FCF Per Share
KRW -2,522
Financing CF
21,425,087,730
Fiscal Year End
December
Founded
2,016
Goodwill
14,336,000
Income Tax
KRW 3.6M
Investing CF
-5,570,544,570
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Ma150
54,471
Ma150ch
27.59%
Ma20
61,350
Ma20ch
13.28%
Net CF
7,511,007,260
Next Earnings Date
2026-05-28
Open
61,100
Position In Range
84.85
Ppne
26,116,349,030
Price Date
2026-05-08
Ptbv Ratio
141.3
Relative Volume
3.71x
Revenue
12,979,352,490x
SBC By Revenue
7.16x
Share Based Comp
929,207,000
Tax By Revenue
0.03x
Tr6m
162.26%
Volume
90,199
Z Score
-0.97
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/376270 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/376270 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+228.6%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/376270?

Insider, institutional, and short-interest positioning.

Institutional ownership
+4.4%
Share of float held by funds and institutions
Insider ownership
+26.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+10.7%
Negative means the company is buying back shares.
Technical

KOSDAQ/376270 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.8
Neutral momentum band
Price vs 200-day MA
+51.2%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
2.02
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/376270

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/376270 stock rating?

kosdaq/376270 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/376270 analysis?

The full report lives at /stocks/kosdaq/376270/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/376270?

The latest report frames kosdaq/376270 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/376270 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.